- Healthcare software provider EMIS Group said trading for the half year had been in line with its expectations with revenue ahead of the prior year. The company also left its expectations for the full year remain unchanged.

In EMIS Health, the group maintained its NHS market share, while the GP IT Futures English GP Framework renewal process had now moved into the formal procurement phase, with successful bidders expected to be announced in September 2019.

EMIS Enterprise, meanwhile, continued to make 'good progress,' including a number of commercial licence deals for both continuing and legacy products, helping to focus the product portfolio, the company said.

The group's net cash at 30 June 2019 was £26.7m, up from £15.6m in December last year, with the seasonal first half working capital inflow and proceeds from the disposal of the Specialist & Care business in part offset by the purchase of £3.6m of shares by the group's Employee Benefit Trust.

'We are focussed on the execution of our strategic plan to provide increased revenue growth and improved margins, towards 30%, in the medium term,' said Andy Thorburn, CEO of EMIS Group.

'We continue to invest in our clinical, product management and global software development teams while, in parallel, streamlining our support and back office operations through the deployment of new systems and processes.'

At 8:51am: [LON:EMIS] EMIS Group PLC share price was -8p at 1202p

Story provided by